[June 10, 2015]

Research and Markets: Global Celiac Disease Pipeline Review, H1 2015 - 10 Companies & 20 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/p8fhcx/celiac_disease) has announced the addition of the "Celiac Disease - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Celiac Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Celiac Disease and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strenthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• ActogeniX NV
• Alba Therapeutics Corporation
• Alvine Pharmaceuticals, Inc.
• Avaxia Biologics, Inc.
• Calypso Biotech SA
• Dr. Falk Pharma GmbH
• ImmusanT, Inc.
• Provid Pharmaceuticals, Inc.
• Sitari Pharmaceuticals, Inc.
• Zedira GmbH

Drug Profiles

• AVX (News - Alert)-176
• Biologic to Antagonize HLA-DQ2 for Celiac Disease
• Biologic to Target Gluten and IL-10 for Celiac Disease
• Biologics to Inhibit Transglutaminase 2 for Celiac Disease
• CALY-002
• Enzyme for Celiac Disease
• Enzymes for Celiac Disease
• ERW-1041E
• larazotide acetate
• latiglutenase
• Monoclonal Antibody to Inhibit IL-2 and IL-15 for Oncology and Gastrointestinal Disorders
• Nexvax-2
• Nexvax-3
• Peptide for Celiac Disease
• Synthetic Peptide to Inhibit DQ2/DQ8 for Celiac Disease and Type 1 Diabetes
• ZED-101
• ZED-1098
• ZED-1219
• ZED-1227
• ZED-754

For more information visit http://www.researchandmarkets.com/research/p8fhcx/celiac_disease

View source version on businesswire.com: http://www.businesswire.com/news/home/20150610005597/en/

[ Back To TMCnet.com's Homepage ]